These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8576791)

  • 1. Structural cardiovascular alterations and blood pressure variability in human hypertension.
    Mancia G; Giannattasio C; Turrini D; Grassi G; Omboni S
    J Hypertens Suppl; 1995 Aug; 13(2):S7-14. PubMed ID: 8576791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The heart and vascular changes in hypertension.
    Leonetti G; Cuspidi C
    J Hypertens Suppl; 1995 Aug; 13(2):S29-34. PubMed ID: 8576785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
    Ketelhut S; Franz IW; Ketelhut RG
    High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large artery function and alterations in hypertension.
    London GM
    J Hypertens Suppl; 1995 Aug; 13(2):S35-8. PubMed ID: 8576786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension and Organ Damage in Women.
    Muiesan ML; Paini A; Aggiusti C; Bertacchini F; Rosei CA; Salvetti M
    High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):245-252. PubMed ID: 29943358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension and left ventricular hypertrophy: what is the link?
    Arthur A; McNulty CM
    R I Med; 1993 May; 76(5):245-8. PubMed ID: 8518500
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni.
    Mancia G; Carugo S; Grassi G; Lanzarotti A; Schiavina R; Cesana G; Sega R;
    Hypertension; 2002 Mar; 39(3):744-9. PubMed ID: 11897756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Powerful hemodynamic determinants of left ventricular mass.
    Insa R; Sol JM
    Int J Cardiol; 1992 Oct; 37(1):123-4. PubMed ID: 1428283
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of regression of left ventricular hypertrophy on cardiac function in hypertension.
    Omotoso AB; Dunn FG
    Eur Heart J; 1992 Sep; 13 Suppl D():107-10. PubMed ID: 1396853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
    Dahlöf B
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S9-14. PubMed ID: 16075032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial hypertension and left ventricular dysfunction: pathophysiology, diagnosis and therapy].
    Kleber FX; Doering W
    Cardiology; 1993; 82 Suppl 2():9-21. PubMed ID: 8519033
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood pressure variability in controlled and uncontrolled blood pressure and its association with left ventricular hypertrophy and diastolic function.
    Wittke EI; Fuchs SC; Moreira LB; Foppa M; Fuchs FD; Gus M
    J Hum Hypertens; 2016 Aug; 30(8):483-7. PubMed ID: 26467817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrendipine vs. captopril in essential hypertension: effects on circadian blood pressure and left ventricular hypertrophy.
    Machnig T; Henneke KH; Engels G; Pongratz G; Schmalzl M; Gellert J; Bachmann K
    Cardiology; 1994; 85(2):101-10. PubMed ID: 7954561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy.
    Rizzoni D; Muiesan ML; Porteri E; Castellano M; Zulli R; Bettoni G; Salvetti M; Monteduro C; Agabiti-Rosei E
    J Hypertens; 1997 Feb; 15(2):197-204. PubMed ID: 9469796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morning rise of blood pressure assessed by home blood pressure monitoring is associated with left ventricular hypertrophy in hypertensive patients receiving long-term antihypertensive medication.
    Shibuya Y; Ikeda T; Gomi T
    Hypertens Res; 2007 Oct; 30(10):903-11. PubMed ID: 18049021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension].
    De Simone R; Irace L; Perna B; Caruso C; Guida M; Iacono A
    Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure variability and organ damage.
    Mancia G; Frattola A; Parati G; Santucciu C; Ulian L
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S6-11. PubMed ID: 7603077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in left ventricular geometry during antihypertensive treatment.
    Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
    Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of detectable regression of human hypertensive left ventricular hypertrophy following drug treatment for 1 year.
    Laufer E; Reid C; Qi XL; Jennings GL
    Clin Exp Pharmacol Physiol; 1998; 25(3-4):208-15. PubMed ID: 9590570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.